HDAC2 is reported to be responsible for the loss of adenomatous polyposis coli (APC) expression in colorectal cancer (CRC) (Zhu et al., 2004) and displays increased expression in cervical (Huang et al., 2005) and gastric (Song et al., 2005) carcinomas. Here, APC is linked to colorectal cancer.